Latest Share Buybacks News

Page 8 of 21
CVC Limited has reversed its fortunes with a $0.5 million net profit after tax for FY25, driven by strong property investment income and strategic land developments, while maintaining a cautious capital management approach and withholding dividends.
Eva Park
Eva Park
26 Aug 2025
Earlypay Limited reported a 24% rise in underlying net profit after tax for FY25, driven by robust growth in equipment finance and improved credit performance, while declaring a fully franked dividend and forecasting further earnings growth in FY26.
Claire Turing
Claire Turing
26 Aug 2025
IVE Group Limited reported a 69% jump in net profit for FY25 despite a slight revenue dip, driven by margin expansion and operational efficiencies. The company maintains a strong balance sheet and outlines ambitious growth and sustainability plans for FY26.
Victor Sage
Victor Sage
26 Aug 2025
G8 Education reported a 3.7% revenue decline but a 12.4% rise in net profit for the first half of 2025, amid ongoing cost-of-living challenges impacting occupancy. The company declared a dividend and announced a share buyback, underscoring confidence despite sector headwinds.
Victor Sage
Victor Sage
26 Aug 2025
G8 Education Limited reported a 12.4% rise in net profit to $22.5 million for the first half of 2025, navigating lower occupancy and divestments with strategic cost controls and capital management.
Victor Sage
Victor Sage
26 Aug 2025
Tribeca Global Natural Resources Limited has reversed last year’s loss to report a $5 million profit and declared a fully franked dividend, while unveiling a significant share buyback program to address its discount to net tangible assets.
Maxwell Dee
Maxwell Dee
26 Aug 2025
Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.
Ada Torres
Ada Torres
26 Aug 2025
Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.
Ada Torres
Ada Torres
26 Aug 2025
GTN Limited reported a modest revenue decline and a sharper EBITDA drop in FY25 but rewarded shareholders with strong returns including dividends, buybacks, and a significant capital return.
Elise Vega
Elise Vega
25 Aug 2025
GTN Limited reported a 2% revenue decline to AUD 180.2 million and a net loss after tax of AUD 6.06 million for FY25, alongside a capital return approved by shareholders. The company is navigating operational challenges while positioning for future growth across its global media platform.
Elise Vega
Elise Vega
25 Aug 2025
Underwood Capital Limited has reported a return to profitability for the year ended 30 June 2025, driven by gains in its listed securities portfolio and a strategic share buyback that enhanced net tangible asset backing per share.
Claire Turing
Claire Turing
25 Aug 2025
Vita Life Sciences delivered a robust first half in 2025 with record revenue and profit growth, driven by strong performances in Australia and Southeast Asia. The company also raised its interim dividend and expanded marketing efforts.
Ada Torres
Ada Torres
25 Aug 2025